retatrutide nonalcoholic steatohepatitis nash trial Current and future pharmacological therapies for NAFLD/NASH | Journal of Gastroenterology Triple hormone receptor agonist retatrutide
Pay in 4 interest-free payments of $7.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7





























